AAAAAA

   
Results: 1-7 |
Results: 7
SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF -N,N-DIMETHYL-4H-IMIDAZO[4,5,1-IJ]QUINOLIN-5-AMINE AND ITS METABOLITES
Authors: HEIER RF DOLAK LA DUNCAN JN HYSLOP DK LIPTON MF MARTIN IJ MAURAGIS MA PIERCEY MF NICHOLS NF SCHREUR PJKD SMITH MW MOON MW
Citation: Rf. Heier et al., SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF -N,N-DIMETHYL-4H-IMIDAZO[4,5,1-IJ]QUINOLIN-5-AMINE AND ITS METABOLITES, Journal of medicinal chemistry, 40(5), 1997, pp. 639-646
SUBSTITUTED 4-AMINOPIPERIDINES HAVING HIGH IN-VITRO AFFINITY AND SELECTIVITY FOR THE CLONED HUMAN DOPAMINE D-4 RECEPTOR
Authors: SCHLACHTER SK POEL TJ LAWSON CF DINH DM LAJINESS ME ROMERO AG REES SA DUNCAN JN SMITH MW
Citation: Sk. Schlachter et al., SUBSTITUTED 4-AMINOPIPERIDINES HAVING HIGH IN-VITRO AFFINITY AND SELECTIVITY FOR THE CLONED HUMAN DOPAMINE D-4 RECEPTOR, European journal of pharmacology, 322(2-3), 1997, pp. 283-286
MAN-1-YL)ETHYL]-PIPERAZIN-1-YL]BENZENESULFONAMIDE, A SELECTIVE DOPAMINE D-4 ANTAGONIST
Authors: TENBRINK RE BERGH CL DUNCAN JN HARRIS DW HUFF RM LAHTI RA LAWSON CF LUTZKE BS MARTIN IJ REES SA SCHLACHTER SK SIH JC SMITH MW
Citation: Re. Tenbrink et al., MAN-1-YL)ETHYL]-PIPERAZIN-1-YL]BENZENESULFONAMIDE, A SELECTIVE DOPAMINE D-4 ANTAGONIST, Journal of medicinal chemistry, 39(13), 1996, pp. 2435-2437
SYNTHESIS AND EVALUATION OF PHARMACOLOGICAL AND PHARMACOKINETIC PROPERTIES OF MONOPROPYL ANALOGS OF -[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, -[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, AND 8-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN - CENTRAL DOPAMINE ANDSEROTONIN RECEPTOR ACTIVITY
Authors: SONESSON C BARF T NILSSON J DIJKSTRA D CARLSSON A SVENSSON K SMITH MW MARTIN IJ DUNCAN JN KING LJ WIKSTROM H
Citation: C. Sonesson et al., SYNTHESIS AND EVALUATION OF PHARMACOLOGICAL AND PHARMACOKINETIC PROPERTIES OF MONOPROPYL ANALOGS OF -[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, -[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN, AND 8-[[(TRIFLUOROMETHYL)SULFONYL]OXY]-2-AMINOTETRALIN - CENTRAL DOPAMINE ANDSEROTONIN RECEPTOR ACTIVITY, Journal of medicinal chemistry, 38(8), 1995, pp. 1319-1329
SYNTHESIS AND BIOLOGICAL-ACTIVITY OF C-5 MODIFIED DERIVATIVES OF (-AJ76 AND (+)-UH232 - INCREASED DOPAMINE D3 RECEPTOR PREFERENCE AND IMPROVED PHARMACOKINETIC PROPERTIES())
Authors: HAADSMASVENSSON SR SMITH MW LIN CH DUNCAN JN
Citation: Sr. Haadsmasvensson et al., SYNTHESIS AND BIOLOGICAL-ACTIVITY OF C-5 MODIFIED DERIVATIVES OF (-AJ76 AND (+)-UH232 - INCREASED DOPAMINE D3 RECEPTOR PREFERENCE AND IMPROVED PHARMACOKINETIC PROPERTIES()), Bioorganic & medicinal chemistry letters, 4(5), 1994, pp. 689-694
EVALUATION OF A TEMPLATE MODEL OF THE CYP2D6 ACTIVE-SITE BY EXPERIMENTAL TESTING OF COMPOUNDS WITH RECOMBINANT HUMAN CYP2D6
Authors: BULSARA D ACKLAND MJ DUNCAN JN REES SA ELLIS SW LENNARD MS TUCKER GT
Citation: D. Bulsara et al., EVALUATION OF A TEMPLATE MODEL OF THE CYP2D6 ACTIVE-SITE BY EXPERIMENTAL TESTING OF COMPOUNDS WITH RECOMBINANT HUMAN CYP2D6, The FASEB journal, 8(7), 1994, pp. 10001244-10001244
ORALLY-ACTIVE CENTRAL DOPAMINE AND SEROTONIN RECEPTOR LIGANDS - ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, AND METHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS AND THEFORMATION OF ACTIVE METABOLITES IN-VIVO
Authors: SONESSON C BOIJE M SVENSSON K EKMAN A CARLSSON A ROMERO AG MARTIN IJ DUNCAN JN KING LJ WIKSTROM H
Citation: C. Sonesson et al., ORALLY-ACTIVE CENTRAL DOPAMINE AND SEROTONIN RECEPTOR LIGANDS - ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, ETHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS, AND METHYL)SULFONYL]OXY]-2-(DI-N-PROPYLAMINO)TETRALINS AND THEFORMATION OF ACTIVE METABOLITES IN-VIVO, Journal of medicinal chemistry, 36(22), 1993, pp. 3409-3416
Risultati: 1-7 |